Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Apexbio Technology LLC MLi-2 1627091-47-7 1mL(10 mM in DMSO)
Supplier: Apexbio Technology LLC BA36835.1
MLi-2 (CAS 1627091-47-7) is an orally bioavailable highly selective inhibitor of LRRK2 (leucine-rich repeat kinase 2) a kinase implicated in the pathogenesis of Parkinson s disease MLi-2 demonstrates potent inhibitory activity with an IC50 of 0 76 nM By targeting LRRK2 MLi-2 is utilized in preclinical studies to investigate LRRK2-related signaling pathways and assess the therapeutic potential of LRRK2 inhibition in neurodegenerative disorders such as Parkinson s disease
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?